<DOC>
	<DOCNO>NCT02413918</DOCNO>
	<brief_summary>1 . To assess acute long-term bimodal efficacy iloperidone ( IL ) , adjunct ongoing treatment lithium ( Li ) divalproex ( DIV ) lamotrigine ( LAM ) combination three thereof , group patient index episode mixed state BD . 2 . To assess background , baseline feature , behavioral component characterize treatment response/non-response acute long term management MS</brief_summary>
	<brief_title>Iloperidone Mixed States Bipolar Disorder</brief_title>
	<detailed_description>This prospective 20-week , open-label study iloperidone add ongoing treatment regimen mood stabilizer ( Li DIV LAM combination ) acute maintenance treatment MS- Total number subject : 40 . Severity illness psychopathological feature measure follow rating scale : YMRS , MADRS , CGI-S GAS , BISS . The study monitor safety tolerability combination iloperidone plus mood stabilizer . Efficacy Measures : Primary efficacy measure include 1 ) Mixed effect repeat measure change baseline BISS total score , secondarily , manic depression subscale score . Secondary Efficacy Measures : 1 ) response define 50 % reduction YMRS MADRS 2 ) Time intervention discontinuation mood episode . Iloperidone initiate 2 mg hs day 1 increase 4mg hs day 2 , 8 mg h day 3 . All patient iloperidone titrated receive dosage least 12 mg day . Dosages titrate 24 mg day base tolerability clinical indication . Dosage iloperidone reduce 6 mg day patient develop side effect necessitate reduction dosage</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>1 . Male female ; 2 . Age 18 year old 3 . Patients : Li stable dose 2 week longer , serum level screen great equal 0.5 mEq/l OR DIV dose 2 week longer , serum level screen great equal 45 ug/ml OR LAM ( dosage/day â‰¥100mg ) stable dose 2weeks longer OR Any combination 3a , 3b , 3c 4 . Patients meet DSMIV TR diagnosis bipolar disorder , I II , assess use MINI , ( Sheehan et al. , 1998 ) PLUS ONE criterion 5 6 7 5 . Patients meet DSMIV TR diagnostic criterion mixed manic episode Young Mania Rating Scale ( YMRS ) score &gt; /=14 Montgomery Asberg Depression Rating Scale ( MADRS ) score &gt; /=14 6 . Patients meet criterion manic/hypomanic episode least 2 day simultaneous presence Young Mania Rating Scale ( YMRS ) score &gt; /=14 PLUS Montgomery Asberg Depression Rating Scale ( MADRS ) score &gt; /=14 ; 7 . Patients meet DSMIV TR diagnostic criterion major depressive episode simultaneous presence MADRS score &gt; /=14 PLUS meeting criterion manic/hypomanic episode least 2 day simultaneous presence Young Mania Rating Scale ( YMRS ) score &gt; /=14 1 . Patients current Axis I diagnosis schizophrenia , schizophreniform disorder , schizoptypal disorder , bipolar disorder psychotic subtype require hospitalization , drug induce mania AIDS induce mania 2 . Women positive pregnancy test lactate 3 . Women childbearing potential practicing clinically accept method contraception 4 . Patients general medical condition contraindicate psychoactive medication uncontrolled medical disorder central nervous system disease . 5 . Patients whose clinical status require inpatient day hospital treatment 6 . History severe side effect associate therapeutic dos Li , DIV , LAM 7 . Alcohol drug dependent time enrollment 8 . Suicidal time enrollment . 9 . Current previous exposure iloperidone 10 . Patients take medication cause QTC prolongation 11 . Patients serious cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>